Record NNP B-NP O
date NN I-NP O
: : O O
2094-12-10 CD O B-DATE
Internal NNP B-NP O
Medicine NNP I-NP O
Medical NNP I-NP O
Student NNP I-NP O
Admission NNP I-NP O
Note NNP I-NP O
- : O O
Willie NNP B-NP B-DOCTOR
Nix NNP I-NP I-DOCTOR
, , O O
TMS NNP B-NP B-ORGANIZATION
III NNP I-NP O
Name VB B-VP O
: : O O
Oreilly NNP B-NP I-PATIENT
, , O I-PATIENT
Uriah NNP B-NP I-PATIENT
MR# NNP B-NP O
7916007 CD I-NP B-MEDICALRECORD
PCP NN B-NP O
: : O O
Kevin NNP B-NP B-DOCTOR
Patterson NNP I-NP I-DOCTOR
Date NNP B-NP O
: : O O
12/09/94 CD O B-DATE
Source NN B-NP O
: : O O
Patient NNP B-NP O
and CC I-NP O
Medical NNP I-NP O
Notes NNPS I-NP O
CC NNP B-NP O
: : O O
SOB NNP B-NP O
, , O O
DOE VB B-VP O
x NN B-NP O
5 CD B-NP O
days NNS I-NP O
HPI NNP B-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
73 CD I-NP B-AGE
yo NNP I-NP O
male NN I-NP O
w/ VBD B-VP O
a DT B-NP O
complicated JJ I-NP O
PMH NNP I-NP O
that WDT B-NP O
includes VBZ B-VP O
HTN NNP B-NP O
, , I-NP O
DM NNP I-NP O
, , I-NP O
hyperlipidemia NN I-NP O
, , O O
CAD NNP B-NP O
, , O O
and CC O O
a DT B-NP O
past JJ I-NP O
MI NNP I-NP O
, , O O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
placement NN I-NP O
of IN B-PP O
an DT B-NP O
AICD NNP I-NP O
, , O O
who WP B-NP O
now RB B-ADVP O
p/w VBP B-VP O
severe JJ B-NP O
SOB NNP I-NP O
and CC I-NP O
DOE. NNP I-NP O
Five CD I-NP O
days NNS I-NP O
PTA NNP I-NP O
, , O O
the DT B-NP O
Pt NNP I-NP O
became VBD B-VP O
SOB NNP B-NP O
while IN B-PP O
walking VBG B-VP O
up IN B-PRT O
the DT B-NP O
stairs NNS I-NP O
to TO B-PP O
his PRP$ B-NP O
apartment NN I-NP O
on IN B-PP O
the DT B-NP O
3rd JJ I-NP O
floor NN I-NP O
. . O O
He PRP B-NP O
took VBD B-VP O
a DT B-NP O
SL JJ I-NP O
NG NN I-NP O
pill NN I-NP O
which WDT B-NP O
he PRP B-NP O
says VBZ B-VP O
alleviated VBN I-VP O
the DT B-NP O
SOB NNP I-NP O
and CC O O
allowed VBD B-VP O
him PRP B-NP O
to TO B-VP O
continue VB I-VP O
. . O O
Over IN B-PP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
his PRP$ B-NP O
SOB NNP I-NP O
became VBD B-VP O
progressively RB B-ADJP O
worse JJR I-ADJP O
and CC O O
occurred VBD B-VP O
at IN B-PP O
rest NN B-NP O
. . O O
His PRP$ B-NP O
SOB NNP I-NP O
would MD B-VP O
awaken VB I-VP O
him PRP B-NP O
from IN B-PP O
his PRP$ B-NP O
sleep NN I-NP O
, , O O
occurring VBG B-VP O
3-4x/ JJ B-NP O
night NN I-NP O
. . O O
He PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
SL NNP B-NP O
NG VBD B-VP O
pills NNS B-NP O
alleviated VBN B-VP O
his PRP$ B-NP O
PND. NNP I-NP O
The DT B-NP O
Pt NNP I-NP O
sleeps VBZ B-VP O
on IN B-PP O
one CD B-NP O
pillow NN I-NP O
. . O O
During IN B-PP O
the DT B-NP O
course NN I-NP O
of IN B-PP O
his PRP$ B-NP O
worsening VBG I-NP O
SOB NNP I-NP O
, , O O
his PRP$ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
decreased VBD B-VP O
from IN B-PP O
a DT B-NP O
baseline NN I-NP O
of IN B-PP O
walking VBG B-VP O
2.5 CD B-NP O
hours NNS I-NP O
without IN B-PP O
any DT B-NP O
SOB NNP I-NP O
to TO B-PP O
walking VBG B-VP O
for IN B-NP O
1.5 CD I-NP O
hours NNS I-NP O
with IN B-PP O
multiple JJ B-NP O
stops NNS I-NP O
due RB B-ADVP O
to TO B-PP O
SOB. NNP B-NP O
These DT B-NP O
episodes NNS I-NP O
of IN B-PP O
SOB NNP B-NP O
were VBD B-VP O
not RB I-VP O
associated VBN I-VP O
w/ NN B-NP O
CP CD I-NP O
( -LRB- I-NP O
pleuritic NN I-NP O
or CC O O
otherwise RB B-NP O
) -RRB- I-NP O
, , I-NP O
palpitations NNS I-NP O
, , I-NP O
F/C NNP I-NP O
, , I-NP O
N/V NNP I-NP O
, , I-NP O
diaphoresis NN I-NP O
, , I-NP O
abdominal JJ I-NP O
discomfort NN I-NP O
, , O O
or CC O O
pain NN B-NP O
in IN B-PP O
his PRP$ B-NP O
arms NNS I-NP O
or CC I-NP O
jaw NN I-NP O
. . O O
Also RB B-ADVP O
during IN B-PP O
this DT B-NP O
time NN I-NP O
, , O O
the DT B-NP O
Pt NNP I-NP O
noted VBD B-VP O
progressive JJ B-ADJP O
b/l IN B-PP O
swelling VBG B-VP O
of IN B-PP O
his PRP$ B-NP O
legs NNS I-NP O
( -LRB- B-VP O
from IN B-PP O
ankles NNS B-NP O
to TO B-PP O
knees NNS B-NP O
) -RRB- O O
and CC O O
increasing VBG B-VP O
abdominal JJ B-NP O
girth NN I-NP O
. . O O
He PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
his PRP$ B-NP O
legs NNS I-NP O
would MD B-VP O
pit VB I-VP O
when WRB B-ADVP O
he PRP B-NP O
pressed VBD B-VP O
on IN B-PP O
them PRP B-NP O
. . O O
The DT B-NP O
LE JJ I-NP O
swelling VBG I-NP O
were VBD B-VP O
not RB I-VP O
associated VBN I-VP O
w/ IN B-PP O
calf NN B-NP O
pain NN I-NP O
. . O O
On IN B-PP O
the DT B-NP O
day NN I-NP O
before IN B-PP O
admission NN B-NP O
, , O O
however RB B-ADVP O
, , O O
he PRP B-NP O
did VBD B-VP O
develop VB I-VP O
a DT B-NP O
non-productive JJ I-NP O
, , I-NP O
dry JJ I-NP O
cough NN I-NP O
. . O O
On IN B-PP O
the DT B-NP O
DOA NNP I-NP O
, , O O
his PRP$ B-NP O
Sx NN I-NP O
had VBD B-VP O
worsened VBN I-VP O
to TO B-PP O
the DT B-NP O
point NN I-NP O
where WRB B-ADVP O
he PRP B-NP O
felt VBD B-VP O
like IN B-SBAR O
he PRP B-NP O
needed VBD B-VP O
to TO I-VP O
be VB I-VP O
seen VBN I-VP O
by IN B-PP O
a DT B-NP O
doctor NN I-NP O
. . O O
He PRP B-NP O
was VBD B-VP O
subsequently RB I-VP O
driven VBN I-VP O
to TO B-PP O
NYSH-East NNP B-NP B-HOSPITAL
by IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
and CC I-NP O
son NN I-NP O
, , O O
where WRB B-ADVP O
he PRP B-NP O
was VBD B-VP O
seen VBN I-VP O
and CC O O
then RB B-VP O
re-directed VBD I-VP O
to TO B-PP O
NYSH NNP B-NP B-HOSPITAL
. . O O
At IN B-PP O
NYSH-East NNP B-NP B-HOSPITAL
, , O O
the DT B-NP O
Pt NNP I-NP O
's POS B-NP O
vitals NNS I-NP O
were VBD B-VP O
: : O O
T NNP B-NP O
97.6 CD I-NP O
P NNP I-NP O
52-55 CD I-NP O
BP NNP B-NP O
167/77 CD I-NP O
O2Sat IN B-PP O
98 CD B-NP O
% NN I-NP O
Wt IN B-PP O
188.5# CD B-NP O
w/ JJ I-NP O
clothes NNS I-NP O
. . O O
The DT B-NP O
Pt NNP I-NP O
received VBD B-VP O
Lasix NNP B-NP O
40mg CD I-NP O
IV NNP I-NP O
and CC I-NP O
O2 NNP I-NP O
@ NNP I-NP O
3L/min NNP I-NP O
. . O O
At IN B-PP O
NYSH NNP B-NP B-HOSPITAL
-Ed NNP I-NP O
, , O O
the DT B-NP O
Pt NNP I-NP O
's POS B-NP O
vitals NNS I-NP O
were VBD B-VP O
: : O O
P NNP B-NP O
48 CD I-NP O
BP NNP I-NP O
157/78 CD I-NP O
RR NNP I-NP O
20 CD I-NP O
O2Sat IN B-PP O
99 CD B-NP O
% NN I-NP O
on IN B-PP O
2L CD B-NP O
The DT B-NP O
Pt NNP I-NP O
received VBD B-VP O
ASA NNP B-NP O
325mg CD I-NP O
PO NNP I-NP O
. . O O
Since IN B-PP O
receiving VBG B-VP O
the DT B-NP O
Lasix NNP I-NP O
, , O O
the DT B-NP O
Pt NNP I-NP O
's POS B-NP O
LE JJ I-NP O
edema NN I-NP O
has VBZ B-VP O
drastically RB I-VP O
diminished VBN I-VP O
, , O O
and CC O O
the DT B-NP O
Pt JJ I-NP O
states NNS I-NP O
that IN B-SBAR O
he PRP B-NP O
feels VBZ B-VP O
a DT B-NP O
lot NN I-NP O
better JJR B-ADJP O
. . O O
The DT B-NP O
Pt NNP I-NP O
has VBZ B-VP O
not RB I-VP O
experienced VBN I-VP O
any DT B-NP O
recent JJ I-NP O
weight NN I-NP O
loss NN I-NP O
and CC O O
is VBZ B-VP O
on IN B-PP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
without IN B-PP O
salt NN B-NP O
restriction NN I-NP O
( -LRB- O O
he PRP B-NP O
uses VBZ B-VP O
salt NN B-NP O
2-3x/wk JJ I-NP O
) -RRB- I-NP O
. . O O
He PRP B-NP O
also RB B-ADVP O
claims VBZ B-VP O
that IN B-SBAR O
he PRP B-NP O
is VBZ B-VP O
adherent JJ B-ADJP O
to TO B-PP O
taking VBG B-VP O
his PRP$ B-NP O
meds NNS I-NP O
. . O O
PMHx NNP B-NP O
: : O O
DM . O O
HTN . O O
hyperlipidemia NN B-NP O
s/p VB B-NP O
MI NNP I-NP O
- : O O
6/93 CD O B-DATE
AICD NNP B-NP O
- : O O
9/93 CD O B-DATE
CAD NN B-NP O
w/ NN I-NP O
LAD NN I-NP O
stent NN I-NP O
- : O O
2092 CD O B-DATE
chronic NN B-NP O
anemia NN I-NP O
- : O O
Hct NN B-NP O
w/in IN B-PP O
the DT B-NP O
30-33 JJ I-NP O
range NN I-NP O
colon NN B-NP O
cancer NN I-NP O
resection NN I-NP O
- : O O
2078 CD O B-DATE
diverticular JJ B-NP O
disease NN I-NP O
MEDS NNS B-NP O
: : O O
Amlodipine JJ B-NP O
7.5mg CD I-NP O
QD . O O
ASA NNP B-NP O
Fosinopril NNP B-NP O
40mg CD I-NP O
BID . O O
HCTZ NNP B-NP O
25mg CD I-NP O
QD . O O
Metoprolol NNP B-NP O
100mg CD I-NP O
BID . O O
Lipitor NNP B-NP O
10mg CD I-NP O
QHS . O O
Glucophage NNP B-NP O
1g CD I-NP O
BID . O O
Glyburide NNP B-NP O
10mg CD I-NP O
BID . O O
Omeprazole NNP B-NP O
20mg CD I-NP O
QD . O O
Viagra NNP B-NP O
100mg CD I-NP O
PRN . O O
ALLERGIES NNS B-NP O
: : O O
oxycodone NN B-NP O
, , O O
plavix NN B-NP O
rash NN I-NP O
SOCIAL JJ B-NP O
Hx NNP I-NP O
: : O O
The DT B-NP O
Pt NNP I-NP O
lives VBZ B-VP O
at IN B-PP O
home NN B-NP O
w/ IN B-PP O
his PRP$ B-NP O
wife NN I-NP O
( -LRB- B-VP O
49 CD B-NP B-AGE
yo NNP I-NP O
in IN B-PP O
good JJ B-NP O
health NN I-NP O
) -RRB- I-NP O
and CC O O
son NN B-NP O
( -LRB- I-NP O
27 CD I-NP B-AGE
yo NNP I-NP O
in IN B-PP O
good JJ B-NP O
health NN I-NP O
) -RRB- I-NP O
. . O O
He PRP B-NP O
states VBZ B-VP O
that IN B-SBAR O
he PRP B-NP O
does VBZ B-VP O
not RB I-VP O
drink VB I-VP O
alcohol NN B-NP O
and CC O O
quit VB B-VP O
smoking NN B-NP O
20 CD B-NP O
years NNS I-NP O
ago RB B-ADVP O
after IN B-PP O
having VBG B-VP O
smoked VBN I-VP O
2 CD B-NP O
cigars/day NN I-NP O
for IN B-PP O
20yrs DT B-NP O
. . O O
He PRP B-NP O
denies VBZ B-VP O
using VBG I-VP O
illicit JJ B-NP O
drugs NNS I-NP O
. . O O
He PRP B-NP O
has VBZ B-VP O
2 CD B-NP O
pitbulls NNS I-NP O
at IN B-PP O
home NN B-NP O
and CC O O
has VBZ B-VP O
no DT B-NP O
recent JJ I-NP O
travels NNS I-NP O
. . O O
FAMILY NNP B-NP O
Hx NNP I-NP O
: : O O
No DT B-NP O
FHx NN I-NP O
of IN B-PP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
or CC O O
cancer NN B-NP O
. . O O
ROS NNP B-NP O
: : O O
Const NNP B-NP O
: : O O
No DT B-NP O
lethargy NN I-NP O
, , O O
weight NN B-NP O
gain/loss NN I-NP O
, , O O
good JJ B-NP O
appetite NN I-NP O
. . O O
HEENT NNP B-NP O
: : O O
No DT B-NP O
HA NNP I-NP O
, , O O
vision NN B-NP O
changes NNS I-NP O
, , O O
auras NNS B-NP O
, , O O
or CC O O
injuries NNS B-NP O
. . O O
CV/Resp NN B-NP O
: : O O
See VB B-VP O
HPI. . O O
GI NNP B-NP O
: : O O
No DT B-NP O
diarrhea NN I-NP O
, , O O
difficulty NN B-NP O
swallowing VBG B-VP O
, , O O
abdominal JJ B-NP O
pain NN I-NP O
, , I-NP O
blood NN I-NP O
. . O O
GU NNP B-NP O
: : O O
No DT B-NP O
nocturia NN I-NP O
, , O O
discharge NN B-NP O
, , O O
dysuria NN B-NP O
, , O O
or CC O O
hematuria NN B-NP O
. . O O
No DT B-NP O
increased VBN I-NP O
frequency NN I-NP O
. . O O
Musco/skel/Skin NNP B-NP O
: : O O
Has VBZ B-VP O
arthritis NN B-NP O
. . O O
No DT B-NP O
skin NN I-NP O
changes NNS I-NP O
. . O O
Neuro/Psych NNP B-NP O
: : O O
No DT B-NP O
numbness NN I-NP O
, , O O
tingling VBG B-VP O
, , O O
pain NN B-NP O
, , O O
loss NN B-NP O
of IN B-PP O
coordination NN B-NP O
or CC I-NP O
balance NN I-NP O
, , O O
weakness NN B-NP O
, , O O
or CC O O
loss NN B-NP O
of IN B-PP O
memory NN B-NP O
. . O O
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
: : O O
VS NNP B-NP O
: : O O
T NNP B-NP O
98.7 CD I-NP O
P NNP I-NP O
60 CD I-NP O
BP NNP I-NP O
158/62 CD I-NP O
RR NNP B-NP O
22 CD I-NP O
O2Sat IN B-PP O
94 CD B-NP O
% NN I-NP O
on IN B-PP O
2L CD B-NP O
Gen NNP B-NP O
: : O O
Pt NNP B-NP O
was VBD B-VP O
breathing VBG I-VP O
comfortably RB B-ADVP O
on IN B-PP O
RA. NNP B-NP O
Able NNP I-NP O
to TO B-VP O
get VB I-VP O
out IN B-PP O
of IN B-PP O
bed NN B-NP O
and CC O O
ambulate VB B-VP O
. . O O
Skin NNP B-NP O
: : O O
No DT B-NP O
telangiectasias NN I-NP O
, , O O
palmar NN B-NP O
erythema NN I-NP O
, , O O
or CC O O
rashes NNS B-NP O
. . O O
Acanthosis NN B-NP O
nigricans VBZ B-VP O
present JJ B-ADJP O
on IN B-PP O
the DT B-NP O
back NN I-NP O
of IN B-PP O
the DT B-NP O
neck NN I-NP O
. . O O
HEENT NNP B-NP O
: : O O
nonicteric JJ B-NP O
, , I-NP O
conjunctiva JJ I-NP O
pink JJ I-NP O
, , O O
EOMI NNP B-NP O
. . I-NP O
OP NNP I-NP O
clear JJ I-NP O
without IN B-PP O
exudates NNS B-NP O
, , O O
MMM. . O O
Neck NNP B-NP O
: : O O
supple NN B-NP O
, , O O
NT NNP B-NP O
, , O O
no DT B-NP O
thyromegaly NN I-NP O
, , O O
no DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
, , O O
no DT B-NP O
JVD NNP I-NP O
, , O O
no DT B-NP O
LAD NN I-NP O
Lungs NNP B-NP O
: : O O
CTA NNP B-NP O
and CC I-NP O
percussion NN I-NP O
b/l NN I-NP O
Heart NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
nl JJ B-NP O
S1 NNP I-NP O
and CC I-NP O
S2 NNP I-NP O
, , O O
II/V NNP B-NP O
I PRP B-NP O
SEM VBP B-VP O
at IN B-PP O
LLSB. NNP B-NP O
No DT B-NP O
S3 NN I-NP O
or CC O O
S4 NNP B-NP O
appreciated VBD B-VP O
. . O O
Abd NNP B-NP O
: : O O
+BS NNP B-NP O
, , I-NP O
soft JJ I-NP O
, , I-NP O
NT. NNP I-NP O
Distended VBD B-VP O
abdomen NN B-NP O
. . O O
Liver VBD B-VP O
edge NN I-VP O
palpable JJ B-NP O
3cm NN I-NP O
from IN B-PP O
costal JJ B-NP O
border NN I-NP O
. . O O
Paradoxical NNP B-NP O
rise NN I-NP O
during IN B-PP O
inspiration NN B-NP O
. . O O
No DT B-NP O
caput NN I-NP O
medusa NN I-NP O
. . O O
Extr NNP B-NP O
: : O O
Pitting NNP B-NP O
edema VBD B-VP O
6in CD B-NP O
from IN B-PP O
ankle NN B-NP O
b/l JJ I-NP O
in IN B-PP O
LE. NNP B-NP O
PT NNP I-NP O
pulses VBZ B-VP O
2+ JJ B-NP O
b/l NN I-NP O
. . O O
No DT B-NP O
cyanosis NN I-NP O
. . O O
Neuro NNP B-NP O
: : O O
AOx3 NNP B-NP O
, , O O
CN NNP B-NP O
II-XII NNP I-NP O
intact JJ I-NP O
. . O O
Motor NNP B-NP O
5/5 VBD B-VP O
throughout IN B-PP O
except IN B-PP O
L NNP B-NP O
arm NN I-NP O
, , O O
which WDT B-NP O
was VBD B-VP O
limited VBN I-VP O
by IN B-PP O
pain NN B-NP O
. . O O
DTR NNP B-NP O
's VBZ B-VP O
not RB I-VP O
appreciated VBN I-VP O
in IN B-PP O
any DT B-NP O
of IN B-PP O
the DT B-NP O
extremities NNS I-NP O
( -LRB- I-NP O
triceps NNS I-NP O
, , O O
brachioradialis NN B-NP O
, , O O
knees NNS B-NP O
, , O O
and CC O O
ankles NNS B-NP O
) -RRB- B-VP O
. . O O
LABS NNP B-NP O
: : O O
Test NNP B-NP O
Description NNP I-NP O
Result NNP I-NP O
Flags NNP I-NP O
Ref NNP I-NP O
. . I-NP O
Range NNP I-NP O
Units . O O
Sodium NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
143 CD I-NP O
( -LRB- I-NP O
135-145 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Potassium NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- B-PP O
3.9 CD B-NP O
( -LRB- I-NP O
3.4-4.8 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
Chloride NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
109 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
100-108 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
CO2 NN B-NP O
( -LRB- I-NP O
Stat NNP I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
25.8 CD I-NP O
( -LRB- I-NP O
23.0-31.9 CD I-NP O
) -RRB- I-NP O
mmol/L . O O
BUN NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- O O
24 CD B-NP O
(8-25 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Creatinine NNP B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NNP I-NP O
) -RRB- I-NP O
1.4 CD I-NP O
( -LRB- I-NP O
0.6-1.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Glucose FW B-NP O
( -LRB- I-NP O
Stat NN I-NP O
Lab NN I-NP O
) -RRB- I-NP O
150 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
70-110 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Calcium NNP B-NP O
9.0 CD I-NP O
( -LRB- I-NP O
8.5-10.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Phosphorus JJ B-NP O
3.1 CD I-NP O
( -LRB- I-NP O
2.6-4.5 CD I-NP O
) -RRB- I-NP O
mg/dl . O O
Magnesium NNP B-NP O
1.4 CD I-NP O
( -LRB- O O
1.4-2.0) CD B-NP O
meq/L NN I-NP O
WBC NNP B-NP O
8.4 CD I-NP O
( -LRB- I-NP O
4.5-11.0) JJ I-NP O
th/cmm NN I-NP O
HCT NNP B-NP O
33.4 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
41.0-53.0) CD I-NP O
% NN I-NP O
HGB NNP B-NP O
10.8 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
13.5-17.5 CD I-NP O
) -RRB- I-NP O
gm/dl . O O
RBC NNP B-NP O
4.14 CD I-NP O
L NNP I-NP O
( -LRB- I-NP O
4.50-5.90 CD I-NP O
) -RRB- I-NP O
mil/cmm . O O
PLT NNP B-NP O
291 CD I-NP O
( -LRB- I-NP O
150-350 CD I-NP O
) -RRB- I-NP O
th/cumm . O O
MCV NN B-NP O
81 CD I-NP O
( -LRB- I-NP O
80-100 CD B-PP O
) -RRB- B-NP O
fl NN I-NP O
MCH NNP B-NP O
26.1 CD I-NP O
( -LRB- I-NP O
26.0-34.0) JJ I-NP O
pg/rbc NN I-NP O
MCHC NNP B-NP O
32.4 CD I-NP O
( -LRB- O O
31.0-37.0) CD B-NP O
g/dl NN I-NP O
RDW NNP B-NP O
14.8 CD I-NP O
H NNP I-NP O
( -LRB- I-NP O
11.5-14.5 CD I-NP O
) -RRB- B-NP O
% NN I-NP O
PT NN B-NP O
11.8 CD I-NP O
( -LRB- I-NP O
11.1-13.1 CD B-PP O
) -RRB- B-NP O
sec NN I-NP O
PT-INR NN B-NP O
0.9 CD I-NP O
PT-INR JJ B-NP O
values NNS I-NP O
are VBP B-VP O
valid JJ B-ADJP O
only RB I-ADJP O
for IN B-PP O
WARFARIN NNP B-NP O
ANTI-COAG NNP I-NP O
THERAPY NNP I-NP O
. . O O
APTT NNP B-NP O
26.0 CD I-NP O
( -LRB- I-NP O
22.1-35.1 CD B-PP O
) -RRB- B-NP O
sec NN I-NP O
Specimen NNP B-NP O
not RB B-ADVP O
received VBD B-VP O
on IN B-PP O
ICE NNP B-NP O
UA-Specific JJ B-NP O
Gravity NNP I-NP O
1.015 CD I-NP O
( -LRB- I-NP O
1.001-1.035 CD I-NP O
) -RRB- O O
UA-pH NNP B-NP O
5.0 CD I-NP O
( -LRB- I-NP O
5.0-9.0) CD O O
UA-WBC NNP B-NP O
Screen NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Nitrite JJ B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Albumin NNP B-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
3+SAMPLE JJ B-NP O
SENT NNP I-NP O
TO TO B-PP O
HEME NNP B-NP O
LAB NNP I-NP O
FOR IN B-PP O
ADDITIONAL NNP B-NP O
TESTING NNP I-NP O
UA-Glucose JJ B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Ketones NNP B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- O O
UA-Occult JJ B-NP O
Blood NN I-NP O
( -LRB- I-NP O
NEG NNP I-NP O
) -RRB- O O
TRACE NN B-NP O
INTACT NN I-NP O
UA-SED-RBC NNP B-NP O
0-2 JJ I-NP O
(0-2 NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
UA-SED-WBC NNP B-NP O
0-2 JJ I-NP O
(0-2 NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
UA-SED-Bacteria NNP B-NP O
NEGATIVE JJ I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
Hyaline NNP B-NP O
Cast NNP I-NP O
0-2 JJ I-NP O
(0-5 CD I-NP O
) -RRB- B-NP O
/lpf NN I-NP O
Squamous NNP B-NP O
Cells NNP I-NP O
NEGATIVE NNP I-NP O
( -LRB- I-NP O
NEG NN I-NP O
) -RRB- B-NP O
/hpf NN I-NP O
Creatine NNP B-NP O
Kinase NNP I-NP O
Isoenz NNP I-NP O
NEGATIVE NNP I-NP O
x2 . O O
Troponin-I JJ B-NP O
NEGATIVE JJ I-NP O
x2 NN I-NP O
EKG NNP B-NP O
: : O O
NSR NNP B-NP O
, , O O
bradycardia NN B-NP O
( -LRB- I-NP O
54bpm IN B-PP O
) -RRB- B-NP O
, , O O
LAE NNP B-NP O
, , O O
TW-flattening NNP B-NP O
in IN B-PP O
V5,V6 NNP B-NP O
. . I-NP O
Biphasic NNP I-NP O
TW NNP I-NP O
in IN B-PP O
V2-V4 NNP B-NP O
. . I-NP O
LVH NNP I-NP O
by IN B-PP O
voltage NN B-NP O
criteria NNS I-NP O
. . O O
No DT B-NP O
difference NN I-NP O
from IN B-PP O
past JJ B-NP O
EKGs NNP I-NP O
. . O O
CXR NNP B-NP O
FINDINGS NNP I-NP O
: : O O
Cardiac NNP B-NP O
AICD NNP I-NP O
projecting VBG B-VP O
over IN B-PP O
the DT B-NP O
left JJ I-NP O
hemithorax NN I-NP O
, , O O
unchanged JJ B-ADJP O
. . O O
Lung NNP B-NP O
fields NNS I-NP O
are VBP B-VP O
clear JJ B-ADJP O
. . O O
Cardiomediastinal NNP B-NP O
contours NNS I-NP O
are VBP B-VP O
unchanged JJ B-ADJP O
. . O O
Right RB B-ADVP O
sided VBD B-VP O
diaphragmatic JJ B-NP O
hernia NN I-NP O
, , O O
unchanged JJ B-ADJP O
. . O O
Bony NNP O O
thorax NN B-NP O
is VBZ B-VP O
unchanged JJ B-ADJP O
. . O O
No DT B-NP O
evidence NN I-NP O
of IN B-PP O
active JJ B-NP O
cardiopulmonary JJ I-NP O
disease NN I-NP O
. . O O
Echo NNP B-NP O
( -LRB- I-NP O
6/93 NN I-NP O
) -RRB- I-NP O
: : O O
EF JJ B-NP O
60 CD I-NP O
% NN I-NP O
, , I-NP O
symmetric JJ I-NP O
LVH CC O O
ASSESSMENT NNP B-NP O
AND CC I-NP O
PLAN NNP I-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
73 CD I-NP O
yo NNP I-NP O
male NN I-NP O
w/ VBD B-VP O
a DT B-NP O
complicated JJ I-NP O
PMH NNP I-NP O
that WDT B-NP O
includes VBZ B-VP O
HTN NNP B-NP O
, , I-NP O
DM NNP I-NP O
, , I-NP O
hyperlipidemia NN I-NP O
, , O O
CAD NNP B-NP O
, , O O
and CC O O
a DT B-NP O
past JJ I-NP O
MI NNP I-NP O
, , O O
which WDT B-NP O
resulted VBD B-VP O
in IN B-PP O
the DT B-NP O
placement NN I-NP O
of IN B-PP O
an DT B-NP O
AICD NNP I-NP O
, , O O
who WP B-NP O
now RB B-ADVP O
p/w VBP B-VP O
SOB. . O O
PE NN B-NP O
- : O O
This DT B-NP O
is VBZ B-VP O
still RB B-ADVP O
possible JJ B-ADJP O
given VBN B-PP O
the DT B-NP I-DATE
lack NN I-NP I-DATE
of IN B-PP O
diagnostic JJ B-NP O
studies NNS I-NP O
to TO B-VP O
rule VB I-VP O
out RP B-PRT O
. . B-NP O
Although IN I-NP O
, , O O
there EX B-NP O
were VBD B-VP O
no RB O O
CP CD B-NP O
or CC O O
calf NN B-NP O
pain NN I-NP O
suggestive NN I-NP O
of IN B-PP O
DVTs NNP B-NP B-AGE
. . O O
Consider VB B-VP O
D-dimer NNP B-NP O
to TO B-VP O
rule VB I-VP O
out RP B-PRT O
recent JJ B-NP O
PE. NN I-NP O
Ischemia NNP B-NP O
- : O O
EKG NN B-NP O
and CC O O
the DT B-NP O
negative JJ I-NP O
set NN I-NP O
of IN B-PP O
cardiac JJ B-NP O
enzymes NNS I-NP O
x2 CC O O
does VBZ B-VP O
not RB I-VP O
suggest VB I-VP O
this DT B-NP O
. . O O
However RB B-ADVP O
, , O O
Pt NNP B-NP O
has VBZ B-VP O
not RB I-VP O
had VBN I-VP O
any DT B-NP O
acute JJ I-NP O
Sx NN I-NP O
while IN O O
on IN B-PP O
the DT B-NP O
floor NN I-NP O
. . O O
PNA NNP B-NP O
- : O O
This DT B-NP O
is VBZ B-VP O
less RBR B-ADJP O
likely JJ I-ADJP O
given VBN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
fever NN B-NP O
or CC O O
elevated VBN B-VP O
WBC NNP B-NP O
. . O O
Tumor NNP B-NP O
- : O O
This DT B-NP O
is VBZ B-VP O
also RB B-ADJP O
less RBR I-ADJP O
likely JJ I-ADJP O
given VBN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
weight NN B-NP O
loss NN I-NP O
, , O O
the DT B-NP O
acute JJ I-NP O
nature NN I-NP O
of IN B-PP O
the DT B-NP O
symptoms NNS I-NP O
, , O O
and CC O O
the DT B-NP O
lacko NN I-NP O
f NN I-NP O
lymphadenopathy NN I-NP O
. . O O
1 CD B-NP O
) -RRB- I-NP O
SOB NNP I-NP O
- : O O
Most RBS B-VP O
likely JJ B-NP O
CHF>PE/DVT>ischemia>>PNA NNP I-NP O
,tumor NN I-NP O
; : O O
however RB B-ADVP O
, , O O
he PRP B-NP O
currently RB B-ADVP O
appears VBZ B-VP O
asymptomatic JJ B-ADJP O
. . O O
PE NN B-NP O
is VBZ B-VP O
still RB B-ADVP O
possible JJ B-ADJP O
given VBN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
diagnostic JJ B-NP O
studies NNS I-NP O
to TO B-VP O
rule VB I-VP O
out RP B-PRT O
, , O O
although IN B-SBAR O
there EX B-NP O
were VBD B-VP O
no DT B-NP O
CP CD I-NP O
or CC O O
calf NN B-NP O
pain NN I-NP O
suggestive NN I-NP O
of IN B-PP O
DVTs NNP B-NP O
, , O O
and CC O O
the DT B-NP O
onset NN I-NP O
was VBD B-VP O
not RB O O
acute JJ B-ADJP O
. . O O
The DT B-NP O
Pt NNP I-NP O
may MD B-VP O
have VB I-VP O
had VBD I-VP O
an DT B-NP O
exertional JJ I-NP O
ischemia NN I-NP O
but CC O O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
CP CD B-NP O
and CC O O
EKGs JJ B-NP O
changes NNS I-NP O
makes VBZ B-VP O
this DT B-NP O
less RBR I-NP O
likely JJ I-NP O
; : O O
however RB B-ADVP O
, , O O
the DT B-NP O
Pt NNP I-NP O
has VBZ B-VP O
been VBN I-VP O
asymptomatic VBN I-VP O
on IN B-PP O
the DT B-NP O
floor NN I-NP O
and CC O O
so RB B-ADVP O
no DT B-NP O
EKG NNP I-NP O
tracings NNS I-NP O
concomitant NN I-NP O
with IN B-PP O
the DT B-NP O
SOB NNP I-NP O
are VBP B-VP O
available JJ B-ADJP O
to TO B-VP O
completely RB I-VP O
rule VB I-VP O
out RP B-ADVP O
this DT B-NP O
possibility NN I-NP O
. . B-NP O
PNA NN I-NP O
and CC I-NP O
tumor NN I-NP O
are VBP B-VP O
less RBR B-ADJP O
likely JJ I-ADJP O
given VBN B-PP O
the DT B-NP O
lack NN I-NP O
of IN B-PP O
fevers NNS B-NP O
and CC I-NP O
chills NNS I-NP O
and CC O O
any DT B-NP O
hx NN I-NP O
of IN B-PP O
weight NN B-NP O
loss NN I-NP O
. . O O
Will MD O O
start VB B-VP O
the DT B-NP O
Pt NNP I-NP O
on IN B-PP O
O2 NNP B-NP O
in IN B-PP O
addition NN B-NP O
to TO B-PP O
his PRP$ B-NP O
normal JJ I-NP O
medicinal JJ I-NP O
regimen NNS I-NP O
of IN B-PP O
diuretics NNS B-NP O
, , O O
beta-blockers NNS B-NP O
, , O O
and CC O O
ACE-I. NNP B-NP O
Will MD B-VP O
consider VB I-VP O
the DT B-NP O
addition NN I-NP O
of IN B-PP O
spironolactone NN B-NP O
. . B-NP O
Order NN I-NP O
echo NN I-NP O
to TO B-VP O
determine VB I-VP O
EF NNP B-NP O
and CC O O
to TO B-VP O
identify VB I-VP O
structural JJ B-NP O
myocardial JJ I-NP O
changes NNS I-NP O
if IN B-PP O
any DT B-NP O
. . O O
Order NNP B-NP O
LFT NNP I-NP O
's VBZ B-VP O
to TO I-VP O
check VB I-VP O
for IN B-NP O
decreased VBD I-NP O
perfusion NN I-NP O
to TO B-PP O
vital JJ B-NP O
organs NNS I-NP O
. . O O
Monitor NN B-VP O
UOP NNP B-NP O
for IN B-PP O
kidney NN B-NP O
functions NNS I-NP O
. . O O
Monitor NN B-NP O
EKG NN I-NP O
for IN B-PP O
any DT B-NP O
changes NNS I-NP O
. . O O
Will NNP B-NP O
send VBP B-VP O
for IN B-PP O
a DT B-NP O
D-dimer NN I-NP O
to TO B-VP O
r/o VB I-VP O
recent JJ B-ADJP O
PE. . O O
2 CD B-NP O
) -RRB- I-NP O
HTN VBP I-NP O
- : O O
Poorly RB B-VP O
controlled VBN I-VP O
, , O O
may MD B-VP O
be VB I-VP O
2o JJ B-ADJP O
to TO B-PP O
missing VBG B-NP O
meds NNS I-NP O
today NN B-NP O
. . O O
Will MD B-VP O
also RB I-VP O
be VB I-VP O
treated VBN I-VP O
using VBG I-VP O
meds NNS B-NP O
for IN B-PP O
CHF. NNP B-NP O
3 LS B-NP O
) -RRB- B-VP O
DM VB I-VP O
- : O O
Sugars NNP B-NP O
elevated VBD B-VP O
. . B-NP O
Will NNP I-NP O
treat NN I-NP O
w/ VBD B-VP O
his PRP$ B-NP O
home NN I-NP O
medication NN I-NP O
of IN B-PP O
glucophage NN B-NP O
and CC I-NP O
glyburide NN I-NP O
. . O O
4 CD B-NP O
) -RRB- I-NP O
Hyperlipidemia NNP I-NP O
- : O O
Stable JJ B-NP O
. . O O
Cont NNP B-NP O
home NN I-NP O
medication NN I-NP O
of IN B-PP O
Lipitor NNP B-NP O
. . O O
5 CD B-NP O
) -RRB- I-NP O
FEN NNP I-NP O
- : O O
Switch NN B-VP O
to TO B-PP O
low JJ B-NP O
salt NN I-NP O
diet NN I-NP O
with IN B-PP O
no DT B-NP O
concentrated JJ I-NP O
sweet JJ B-ADJP O
. . O O
Consider VB B-VP O
a DT B-NP O
diabetic NN I-NP O
diet NN I-NP O
as RB B-ADVP O
well RB I-ADVP O
. . O O
6 CD B-NP O
) -RRB- I-NP O
Dispo NNP B-NP O
- : O O
Will MD B-VP O
d/c , O O
once RB O O
Pt NNP B-NP O
is VBZ B-VP O
stabilized VBN I-VP O
. . O O
Willie NNP B-NP O
Nix NNP I-NP O
, , O O
TMS NNP B-NP O
III NNP I-NP O
Pager NNP B-NP O
: : O O
20243 CD O O
12/10/94 CD B-NP O
Intern NNP I-NP O
addendum NN I-NP O
: : O O
Patient NNP B-NP O
seen VBN B-VP O
and CC I-VP O
examined VBN I-VP O
with IN B-PP O
med JJ B-NP O
student NN I-NP O
above IN B-PP O
. . B-NP O
Agree NNP I-NP O
with IN B-PP O
overall JJ B-NP O
assessment NN I-NP O
above IN B-PP O
. . B-NP O
Briefly NNP I-NP O
: : O O
This DT B-NP O
is VBZ B-VP O
a DT B-NP O
73 CD I-NP O
M NNP I-NP O
with IN B-PP O
a DT B-NP O
hx NN I-NP O
of IN B-PP O
CAD NN B-NP O
s/p NN I-NP O
MI NNP I-NP O
, , O O
s/p NN B-NP O
AICD NNP I-NP O
, , I-NP O
IDDM NNP I-NP O
, , I-NP O
HTN NNP I-NP O
, , I-NP O
and CC I-NP O
hyperlipidemia NN I-NP O
, , O O
who WP B-NP O
presents VBZ B-VP O
with IN B-PP O
DOE NNP B-NP O
, , I-NP O
PND NNP I-NP O
and CC I-NP O
bilateral JJ I-NP O
leg NN I-NP O
edema NN I-NP O
x4 CD B-NP O
days NNS I-NP O
. . O O
DOE NN B-NP O
is VBZ B-VP O
not RB I-VP O
associated VBN I-VP O
with IN B-PP O
anginal JJ B-NP O
symptoms NNS I-NP O
including VBG B-PP O
CP NNP B-NP O
, , I-NP O
nausea NN I-NP O
, , O O
vomiting VBG B-VP O
, , O O
and CC O O
diaphoresis NN B-NP O
, , O O
although IN B-SBAR O
the DT B-NP O
patient NN I-NP O
reports VBZ B-VP O
it PRP B-NP O
is VBZ B-VP O
relieved VBN I-VP O
by IN B-PP O
nitroglycerine NN B-NP O
. . O O
Physical JJ B-NP O
exam NN I-NP O
findings NNS I-NP O
here RB B-ADVP O
are VBP B-VP O
notable JJ B-ADJP O
for IN B-PP O
a DT B-NP O
flat JJ I-NP O
JVP NNP I-NP O
, , O O
absence NN B-NP O
of IN B-PP O
crackles NNS B-NP O
, , O O
2/6 CD B-NP O
SEM NNP I-NP O
at IN B-PP O
LLSB NNP B-NP O
and CC I-NP O
apex NN I-NP O
, , O O
and CC O O
mild JJ B-NP O
, , I-NP O
symmetric JJ I-NP O
, , O O
pitting VBG B-VP O
edema NN B-NP O
in IN B-PP O
bilateral NN B-NP O
lower JJR B-NP O
extremities NNS I-NP O
. . O O
Per IN B-PP O
chart NN B-NP O
notes NNS I-NP O
, , O O
in IN B-PP O
clinic NN B-NP O
he PRP B-NP O
was VBD B-VP O
noted VBN I-VP O
to TO I-VP O
have VB I-VP O
bulging VBG B-NP O
neck NN I-NP O
veins NNS I-NP O
. . O O
Favor NN B-NP O
CHF NNP I-NP O
> NNP I-NP O
?pacer NNP I-NP O
malfunction NN I-NP O
, , O O
ischemia NN B-NP O
> NN I-NP O
PE. NNP I-NP O
CHF NNP I-NP O
is VBZ B-VP O
a DT B-NP O
somewhat RB I-NP O
confusing JJ I-NP O
picture NN I-NP O
as IN B-PP O
symptoms NNS B-NP O
suggest VBP B-VP O
L-sided JJ B-NP O
failure NN I-NP O
with IN B-PP O
pulmonary JJ B-NP O
edema NN I-NP O
while IN B-SBAR O
there EX B-NP O
is VBZ B-VP O
little JJ B-NP O
objective NN I-NP O
data NNS I-NP O
( -LRB- O O
no DT B-NP O
crackles NNS I-NP O
on IN B-PP O
exam NN B-NP O
, , O O
CXR NN B-NP O
clear JJ I-NP O
) -RRB- I-NP O
to TO B-VP O
suggest VB I-VP O
this DT B-NP O
. . O O
Prior RB B-ADVP O
to TO B-PP O
our PRP$ B-NP O
evaluation NN I-NP O
he PRP B-NP O
received VBD B-VP O
40 CD B-NP O
of IN B-PP O
IV NNP B-NP O
Lasix NNP I-NP O
and CC O O
diuresed VBD B-VP O
at IN B-NP O
least JJS I-NP O
one CD I-NP O
liter NN I-NP O
( -LRB- I-NP O
with IN B-PP O
subjective JJ B-NP O
improvement NN I-NP O
) -RRB- I-NP O
, , O O
which WDT B-NP O
may MD B-VP O
account VB I-VP O
for IN B-PP O
this DT B-NP O
discrepancy NN I-NP O
. . O O
Plan NNP B-NP O
is VBZ B-VP O
for IN B-PP O
echo NN B-NP O
to TO B-VP O
evaluate VB I-VP O
his PRP$ B-NP O
LV NNP I-NP O
function NN I-NP O
, , O O
pacer NN B-NP O
interrogation NN I-NP O
, , O O
and CC O O
stress NN B-NP O
. . O O
D-dimer NN B-NP O
should MD B-VP O
be VB I-VP O
sufficient JJ B-ADJP O
to TO B-VP O
pursue VB I-VP O
PE NN B-NP O
as IN B-PP O
this DT B-NP O
is VBZ B-VP O
a DT B-NP O
low-prob JJ I-NP O
possibility NN I-NP O
. . O O
Noah NNP B-NP O
Escobar NNP I-NP O
, , O O
MD NNP B-NP O
, , O O
PhD NNP B-NP O
Internal NNP B-NP O
Medicineintern NNP I-NP O
Pager NNP B-NP O
# # I-NP O
08163 CD O O
